Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats

This publication has 57 references indexed in Scilit:

• Evidence for TNFα action on excitatory and inhibitory neurotransmission in the central amygdala: A brain site influenced by stress
  Brain, Behavior, and Immunity, 2013
• Disruption of the Serotonergic System after Neonatal Hypoxia-Ischemia in a Rodent Model
  Neurology Research International, 2012
• Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood–brain barrier in a mice hemorrhage model
  Journal of Neuroscience Methods, 2011
• Open-label add-on treatment trial of minocycline in fragile X syndrome
  BMC Neurology, 2010
• Understanding the molecular mechanism of blood–brain barrier damage in an experimental model of Japanese encephalitis: Correlation with minocycline administration as a therapeutic agent
  Neurochemistry International, 2009
• Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation
  Proceedings of the National Academy of Sciences, 2008
• Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca²⁺ signalling in hippocampal neurons
  European Journal of Neuroscience, 2007
• Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid
  Proceedings of the National Academy of Sciences, 2007
• TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
  Neurobiology of Disease, 2007
• Microglia Potentiate Damage to Blood–Brain Barrier Constituents
  Stroke, 2006